Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2020

View Archived Issues

Stromal cell subtypes identified in TNBC

From variants to treatments in neurology

New selective NKCC1 inhibitor for neurological conditions with impaired chloride ion homeostasis

LION/repRNA-CoV2S vaccine candidate shows efficacy in vivo

Phase III data presented for incobotulinumtoxin A in post-stroke upper-limb spasticity

Beijing Scitech-Mq Pharmaceuticals patents multitarget inhibitors

New phosphodiesterase PDE3A and PDE3B inhibitors disclosed by Bayer, The Broad Institute

Medshine Discovery discovers PD-L1 expression inhibitors

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical identify agents targeting 5-HT2A/DRD3

Aeovian Pharmaceuticals identifies new mTORC1 inhibitors

Vivozon halts phase III study of opiranserin due to COVID-19 outbreak in the U.S.

Homozygous mutations in BTG4 are responsible for the phenotype of zygotic cleavage failure

FDA approves Enspryng for neuromyelitis optica spectrum disorder

Missense variants in the TRIP13 gene cause oocyte meiotic arrest resulting in female infertility

Discovery of autoantibody biomarkers for SLE diagnosis using a 2-phase proteome microarray strategy

Dosing initiates in phase IIa study of ASC-22 in patients with chronic hepatitis B

Starpharma and Chase Sun to develop novel DEP nanoparticle formulations

Specific miRNA-1 oxidation encodes cardiac hypertrophy

Kiadis announces K-NK-cell technology program for the development of COVID-19 therapy

Novavax initiates phase IIb efficacy trial of NVX-CoV2373 in South Africa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...